Gene Query: ABI3BP

Dataset Description Geneva Score
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 150.68
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 150.68
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 93.0
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 89.26
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 74.71
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 63.61
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 58.8
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 56.69
RNA-sequencing of formalin fixed human primary melanoma tissue 56.67
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 55.57
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 54.53
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 54.53
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 51.67
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 48.91
Maturation of human iNSCs 48.77
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 46.97
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 46.79
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 46.61
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 46.52
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 44.88
Analysis of transcriptional regulation by Myt1 and Myt1l 44.37
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 43.78
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 43.71
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  43.67
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 42.72
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 42.72
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 41.55
A sister of NANOG regulates genes expressed in pre-implantation human development 40.95
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 39.51
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 38.5
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 38.29
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 38.29
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 38.29
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 37.14
Gene expression profiling of KSHV-infected periodontal ligament cells 36.88
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 36.77
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 35.96
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 35.96
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 35.76
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 35.18
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 35.0
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 34.69
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 34.63
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 34.63
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 33.79
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 33.5
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 33.27
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 33.27
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 32.92
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 32.6
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 32.19
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 31.83
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 31.56
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 31.39
Global epigenomic reconfiguration during mammalian brain development 31.39
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 31.1
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 30.76
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 30.27
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 30.1
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 29.82
Random mono-allelic expression in MECP2-mutated cells 29.82
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 29.78
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 29.45
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 29.21
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 28.67
Fibroblasts in cholesteatoma activate osteoclasts. 28.58
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 28.24
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 28.23
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 28.23
Gene expression profiling of human and murine in vitro muscle differentiation 28.14
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 28.07
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 28.06
CHD1 regulates cell fate determination by activation of differentiation-induced genes 27.92
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 27.85
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 27.85
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 27.68
UBC9 knockdown in bladder cancer T24 cell lines 27.53
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 27.33
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 27.28
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 26.63
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 26.41
Genome-wide chromatin analysis of Ewing sarcoma 26.36
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 26.36
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 26.26
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 24.51
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 24.5
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 24.4
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 24.35
MYCi361 regulates MYC target genes 24.28
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 24.07
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 24.04
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 23.89
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 23.67
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 23.38
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 23.19
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 23.11
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 22.9
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 22.84
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 22.66
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 22.6
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 22.59
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 22.42
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 21.89
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 21.87
Expression level comparison under dividing and quiescent states in human primary fibroblasts 21.65
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 21.36
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 21.36
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 21.33
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 21.2
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 21.19
RNA-seq of tumor cells following angiopellosis extravasation 20.83
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 20.78
Overexpression and knockdown experiment for circCSNK1G3 20.62
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 20.39
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 20.24
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 20.17
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 19.76
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 19.76
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 19.74
Transciptomic profiling of human fetal lung samples 19.7
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 19.62
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 19.53
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 19.35
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 19.35
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 19.28
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 18.89
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 18.86
The Genomic Landscape of Atypical Fibroxanthoma 18.55
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 18.51
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 18.42
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 18.12
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 18.12
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 18.0
Transcriptomic and gene ontology profiling of the human corneal cell types 17.76
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 17.73
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 17.53
Identification of Atrial Fibrillation associated genes and functional non-coding variants 17.52
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 17.2
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 16.91
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 16.79
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 16.56
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 16.24
RNA-seq of stable and unstable section of human atherosclerotic plaques 16.22
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 16.19
High level DNA repair gene expression in human ES cells 15.96
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 15.66
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 15.62
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 15.41
Control of prostate tumour growth by the long non-coding RNA GHSROS 15.33
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 15.33
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 15.3
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 15.17
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 14.93
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 14.82
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 14.82
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 14.81
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 14.71
Gene expression of thyroid cancer cell lines 14.63
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 14.58
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 14.51
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 14.48
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 14.48
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 14.42
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 14.27
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 14.19
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 14.15
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 14.15
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 14.07
Investigation about fibroblasts of different origins in culture 13.99
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 13.79
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 13.79
A549 cell transcriptome responses to infection with H7N9 influenza virus 13.65
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 13.57
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 13.57
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 13.53
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 13.46
Role of CD133 molecule in WNT response and renal repair 13.44
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 13.39
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 13.04
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 13.02
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 12.99
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 12.91
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 12.77
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 12.59
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 12.59
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 12.49
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 12.49
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 12.42
RNA-seq of MCF10A cells and CAF 12.27
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 12.27
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 12.25
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 12.16
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 12.15
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 12.15
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 12.1
The gene expression profiles of gallbladder cancer 11.7
The expression profiles of GBC liver metastasis 11.62
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 11.61
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 11.6
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 11.6
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 11.53
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 11.51
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 11.49
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 11.46
Single cell transcriptome of peritoneal cells 11.41
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 11.4
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 11.38
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 11.36
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 11.29
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 11.2
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 11.2
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 11.19
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 11.17
RNA-sequencing 10.88
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 10.85
miRNAs affected by antagomiR-17 treatment 10.77
RNA-Seq of Breast and Ovarian Cancer Cell Lines 10.63
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 10.62
Changes in human endometrial gland transcriptome over the window of implantation 10.62
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 10.55
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 10.46
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 10.46
Transcriptome analysis of virus infected tissues 10.43
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 10.43
Gene expression profiling in metabolically heterogeneous human lung tumors 10.42
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 10.41
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 10.34
High-efficiency RNA-based reprogramming of human primary fibroblasts 10.31
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 10.31
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 10.31
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 10.24
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 10.24
TOP2B disturbed the quality of human oocytes with advanced maternal age 10.18
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 10.09
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 10.02
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 9.95
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 9.95
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 9.95
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 9.94
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 9.92
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 9.9
A transcriptome dataset revealing the molecular features of breast cancer stem cells 9.83
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 9.8
Gene expression profiling of papillary thyroid cancer from central and invasive regions 9.8
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 9.79
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 9.79
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 9.78
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 9.71
mRNA differential expression analysis in a human ex vivo model of chronic wounds 9.64
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 9.64
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 9.6
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 9.49
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 9.44
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 9.44
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 9.43
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 9.4
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 9.39
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 9.3
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 9.28
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 9.2
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 9.1
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 9.04
Redifferentiation of expanded human islet β cells by inhibition of ARX 9.04
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 8.99
In vitro modeling of human germ cell development using pluripotent stem cells 8.99
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 8.96
Next Generation Sequencing of human SMA and healthy control Motor Neurons 8.91
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 8.8
The effect of PPARG inhibition on human angiomyolipoma cells 8.79
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 8.76
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 8.71
RNA splicing alteration on glioblastoma and normal neural stem cells 8.69
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 8.68
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 8.61
Transcriptome analysis of human lung epithelial cells 8.6
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 8.6
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 8.6
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 8.53
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 8.48
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 8.47
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 8.47
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 8.44
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 8.39
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 8.39
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 8.34
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 8.22
circRNA-sequencing 8.15
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 8.13
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 8.05
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 7.95
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 7.95
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 7.83
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 7.83
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 7.79
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 7.69
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 7.69
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 7.62
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 7.62
Gene expression alterations of pancreatic intraepithlial neoplasia 7.59
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 7.57
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 7.53
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 7.49
Chromatin landscape of human visceral and subcutaneous adipocytes 7.39
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 7.31
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 7.31
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.31
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 7.28
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.25
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 7.12
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 7.08
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 7.03
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 7.03
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 7.01
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 7.01
Human optic chiasm from healthy controls and multiple sclerosis patients 6.9
Multiple sclerosis and EAE 6.9
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 6.82
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 6.79
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 6.78
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 6.78
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 6.75
EGR1-controlled transcriptome of T HESCs 6.71
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 6.71
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 6.7
RNA sequencing of matched nephrectomy samples [RNA-seq] 6.7
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 6.64
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 6.58
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 6.51
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 6.51
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 6.51
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 6.48
Loss of endometrial plasticity in recurrent pregnancy loss 6.48
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 6.44
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 6.41
Investigate A2M treatment on human prostate cancer and mouse liver 6.39
Investigate A2M treatment on human prostate cancer xenograft in mice 6.39
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 6.38
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 6.38
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 6.32
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 6.31
Identification of Sin3B regulated genes during quiescence 6.29
6.23
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 6.21
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 6.14
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 6.1
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 6.1
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 6.08
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 6.03
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 6.01
Modeling Familial Cancer with iPSC Approaches 6.01
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 5.98
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 5.93
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 5.93
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 5.93
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 5.84
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 5.81
Gene expression profile of CRC-derived HILEC 5.8
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 5.79
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 5.79
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 5.78
The conserved transcriptional landscapes in human spermatogenesis 5.76
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 5.75
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 5.72
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 5.72
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 5.72
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 5.69
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 5.69
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 5.49
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 5.45
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.28
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 5.25
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 5.25
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 5.14
Widespread regulated alternative splicing of single codons accelerates proteome evolution 4.87
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 4.84
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 4.71
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 4.7
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 4.64
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 4.49
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 4.48
Persistence of stem cell metabolism in cancers as a failure of differentiation 4.34
Epigenome regulation during epidermal lineage commitment 4.29
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 4.24
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 4.21
The transcriptome of Kawasaki Disease arteritis 4.19
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 4.17
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 4.12
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 4.12
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 4.12
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 4.12
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 4.05
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 4.05
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 4.01
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 3.97
Measure transcript integrity using RNA-seq data 3.97
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 3.96
NKX2.2 3.96
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 3.96
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 3.95
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 3.91
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 3.91
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 3.9
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.85
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 3.83
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 3.83
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.8
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.8
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 3.71
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 3.68
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 3.61
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 3.42
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 3.39
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 3.37
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 3.36
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.34
Single-cell analysis of adult human ovary using 10X genomics 3.33
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.31
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 3.29
Differential gene expression in Jagged1 treated human dental pulp cells. 3.24
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 3.22
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 3.2
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.19
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 3.19
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 3.19
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 3.1
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 3.05
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.96
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.83
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.79
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 2.76
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 2.75
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 2.65
Aortic Valve Tissue: Stenosis vs. Sclerosis 2.6
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 2.56
Transcriptomes in healthy and CHB fetal hearts 2.53
RNA-seq melanoma 2.51
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 2.5
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.45
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 2.45
Identification of the role of polydom in neurofibromas 2.44
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 2.37
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 2.37
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 2.27
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 2.27
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.21
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.1
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 2.08
RNA expression profiles comparing primary and omental ovarian carcinoma samples 2.07
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.07
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.07
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 1.97
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.91
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.91
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 1.83
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.81
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.76
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.69
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.68
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.68
Molecular analysis of renal cell carcinoma with unclassfied histology 1.63
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.63
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 1.58
Dilated cardiomyopathy vs Myocarditis 1.55
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.51
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.51
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 1.4
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 1.39
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 1.38
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.34
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 1.29
RNA-seq in endometrial stromal tumors 1.29
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.27
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 1.22
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 1.16
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 1.13
Function and hormonal regulation of GATA3 in human first trimester placentation 1.11
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.07
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.06
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.03
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.03
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.0
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.94
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 0.93
Morphological and molecular characterization of human dermal lymphatic collectors 0.76
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 0.75
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.74
mRNA sequencing of oropharyngeal cancer cell lines 0.66
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.64
RNAseq analysis of ruxolitinib treated breast cancers 0.52
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 0.51
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.4
Common inflammatory pathways between NEC and Crohn's disease 0.39
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.34
Characterization of the Merkel cell carcinoma miRNome 0.33
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.33
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 0.29
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.2
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 0.18
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.13
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.1


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation